PCI Mortality and Volume in One Center: Associated?

The relationship between procedure volume and prognosis after a percutaneous coronary intervention remains unclear. Intuitively, we tend to think the larger the volume, the better the results and, consequently, the lower the mortality. But when analyzing the literature, we find studies for and against this thesis.

PCI Mortality and Volume in One Center: Associated?

Evidence does support the idea that volume improves outcomes in specific procedures such as chronic total occlusions, but when considering all PCI procedures in the daily practice, the differences tend to disappear.

 

This study provides current information from one of the few countries with a representative national registry of percutaneous coronary intervention procedures.

 

All adult patients undergoing PCI in 93 national hospitals in the UK between 2007 and 2013 were included. Data was provided by the British Cardiovascular Intervention Society and adjusted for differences.


Also read: Less volume, more mortality: should we worry?


Of 427,467 performed procedures (22% primary PCI) mortality rate at 30 days was 1.9% (4.8% in primary PCI). 87.1% of centers performed between 200 and 2000 procedures a year.

 

In centers that had between 200 and 399 procedures a year, there was a smaller proportion of primary PCI (8.4%) compared to centers with 1500 to 1999 interventions a year (with nearly one fourth of procedures ─24.2%─ in the context of ST elevation MI).

 

However, even though smaller volume centers did less primary PCI procedures, proportionally more were done for MI in the context of cardiogenic shock (8.4% vs 4.3%). This could be explained simply by the fact that more serious cases are generally taken to the nearest center possible.


Also read: Outcomes still associated to operator experience and center volume”.


For the entire cohort (and after multiple adjustments) no evidence of better or worse outcomes were found to be associated to the number of procedures performed in one year. This was true even for primary PCI outcomes.

 

Conclusion

After adjusting for multiple variables, this study supports the idea that there is higher mortality in centers with smaller volume of percutaneous coronary intervention procedures.

 

Editorial Comment

Even though methodologically correct, adjusting for multiple variables is still a limitation to this study; however, given the fact that randomization could be impossible in real life, we must believe these figures. 

 

The difference in cardiogenic shock rates could be explained by the higher selectivity of high volume centers. This requires further research, since a recent study has shown cardiogenic shock patients evolve better in high volume centers.

 

Finally, these data could be true only for places like the UK, where operators performing less than 75 PCI procedures a year are discouraged from practicing. Indeed, in these countries, operators from centers with smaller volume attend PCI sessions for training purposes, to maintain experience. This detail could make all the difference, since “lower volume centers” is not necessarily synonymous with “low volume operators”.

 

Título original: Total Center Percutaneous Coronary Intervention Volume and 30-Day Mortality. A Contemporary National Cohort Study of 427 467 Elective, Urgent, and Emergency Cases

Referencia: Darragh O’Neill et al. Circ Cardiovasc Qual Outcomes. 2017;10:e003186.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...